The French Ministry of Higher Education, Research and Innovation have granted SIRION Biotech a 3-year CIR (Crédit Impôt Recherche) accreditation lasting until end of 2023.
As a result, SIRION Biotech GmbH is now on a list of experts accessible on the Ministry website, and companies based in France that work with us can deduct part of the research funds spent at SIRION Biotech from their taxes. This accreditation is the result of SIRION’s drive to improve support for clients in France and Worldwide, enabling them to go one step closer to developing cutting edge therapies with efficient viral vector technologies.
“It is a great achievement for us in France, a country we believe to be one of the most important in the Gene Therapy and Cell Therapy markets. With this accreditation we reinforce our support to French companies and open new paths towards more R&D collaborations.”, said CEO of SIRION Biotech, Dr. Christian Thirion.
Dr. Francois Vromman, Senior Director, Head of Business Operations, Southern and Western Europe, and Head of SIRION Biotech’s Paris office, added: “We wish to thank the @Businove team with @Romain Bouverot and @Angelique Richard for helping us through the process”
As a result, SIRION Biotech GmbH is now on a list of experts accessible on the Ministry website, and companies based in France that work with us can deduct part of the research funds spent at SIRION Biotech from their taxes. This accreditation is the result of SIRION’s drive to improve support for clients in France and Worldwide, enabling them to go one step closer to developing cutting edge therapies with efficient viral vector technologies.
“It is a great achievement for us in France, a country we believe to be one of the most important in the Gene Therapy and Cell Therapy markets. With this accreditation we reinforce our support to French companies and open new paths towards more R&D collaborations.”, said CEO of SIRION Biotech, Dr. Christian Thirion.
Dr. Francois Vromman, Senior Director, Head of Business Operations, Southern and Western Europe, and Head of SIRION Biotech’s Paris office, added: “We wish to thank the @Businove team with @Romain Bouverot and @Angelique Richard for helping us through the process”
